Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T4 plus T3 sulfate substitution therapy in hypothyroid patients
2010-018663-42Phase 2Completed
- Sponsor
- Bracco Group
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of triiodothyronine sulfate and levothyroxine sodium in hypothyroidism (2 arms), sponsored by Bracco Group. Primary endpoint: Responder rate for maintained metabolic control at visit V3c. Started Jun 2010; status: completed.
02
Drugs
triiodothyronine sulfatelevothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on 2010-018663-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018663-42.